XOPENEX

This brand name is authorized in United States

Active ingredients

The drug XOPENEX contains one active pharmaceutical ingredient (API):

1 Salbutamol
UNII WDQ1526QJM - LEVALBUTEROL HYDROCHLORIDE

Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.

Read about Salbutamol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
XOPENEX Inhalation solution FDA, National Drug Code (US) MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 17478-171, 17478-172, 17478-173, 17478-174

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈